<DOC>
	<DOCNO>NCT00346034</DOCNO>
	<brief_summary>The main purpose protocol evaluate long-term safety pregabalin patient participate previous fibromyalgia Study A0081100 wish receive open-label pregabalin therapy .</brief_summary>
	<brief_title>This Study An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients must meet inclusion criterion precede fibromyalgia Protocol A0081100 , must receive pregabalin/placebo doubleblind condition . Patients may participate study experience serious adverse event previous fibromyalgia Study A0081100 determine related study medication investigator sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>